Business Insider8d
ViiV announces new study data showing zero HIV cases with Apretude
GSK (GSK) announced that ViiV Healthcare, the global specialist HIV company majority owned by GSK, with Pfizer (PFE) and Shionogi (SGIOY) as shareholders, announced new data from two ...
Business Insider8d
ViiV Healthcare announces data from EMBRACE Phase IIb study
ViiV Healthcare, majority owned by GSK (GSK), with Pfizer (PFE) (PE) and Shionogi as shareholders, announced findings from the company’s EMBRACE phase IIb study. The study found that N6LS, given ...
News Medical8d
ViiV Healthcare’s investigational broadly neutralising antibody - N6LS - successfully maintains viral suppression in long-acting treatment of HIV
ViiV Healthcare, the global specialist HIV company majority owned by GSK, with Pfizer and Shionogi as shareholders, today announced positive findings from the company’s EMBRACE phase IIb study.
Yahoo Finance8d
ViiV Healthcare announces new implementation study data showing zero cases of HIV with Apretude, the only long-acting injectable approved for HIV PrEP
LONDON, March 12, 2025--(BUSINESS WIRE)--ViiV Healthcare, the global specialist HIV company majority owned by GSK, with Pfizer and Shionogi as shareholders, today announced new data from two ...
Benzinga.com8d
GSK, Pfizer's ViiV Healthcare Shows Strong HIV Viral Suppression In Latest Study
See today's pick now. ViiV Healthcare announced Wednesday the latest findings from its EMBRACE phase 2b study. The study found that N6LS (VH3810109 or VH109), given every four months in ...
scmp.com2d
Intel’s new CEO plots overhaul of manufacturing and AI operations
Intel’s incoming CEO Lip-Bu Tan has considered significant changes to its chip manufacturing methods and artificial intelligence (AI) strategies ahead of his return to the company on Tuesday ...
PharmiWeb8d
ViiV Healthcare announces new implementation study…
London, 12 March 2025 – ViiV Healthcare, the global specialist HIV company majority owned by GSK, with Pfizer and Shionogi as shareholders, today announced new data from two implementation studies ...
Business Wire8d
ViiV Healthcare’s investigational broadly neutralising antibody - N6LS - successfully maintains viral suppression in long-acting treatment of HIV
LONDON--(BUSINESS WIRE)--ViiV Healthcare, the global specialist HIV company majority owned by GSK, with Pfizer and Shionogi as shareholders, today announced positive findings from the company’s ...
PharmiWeb9d
ViiV Healthcare’s investigational broadly neutralising antibody - N6LS - successfully maintains viral suppression in long-acting treatment of HIV
These results were presented today at the Conference on Retroviruses and Opportunistic Infections (CROI 2025) in San Francisco, U.S. Kimberly Smith, M.D., MPH, Head of Research & Development at ViiV ...
Yahoo Finance8d
Intel hires former board member as new CEO in struggling chipmaker's latest comeback attempt
Struggling chipmaker Intel has hired former board member and semiconductor industry veteran Lip-Bu Tan as the latest in a succession of CEOs to attempt to turn around a once-dominant company that ...
TechRepublic9d
Intel Foundry Shake-Up: TSMC Proposes Shared Takeover with Chip Giants
Intel Foundry Shake-Up: TSMC Proposes Shared Takeover with Chip Giants Your email has been sent Intel’s reluctance and internal divisions Challenges in potential TSMC-Intel partnership Trump is ...